Advertisement

Topics

FDA experts to vote on Spark's groundbreaking gene therapy

08:14 EDT 12 Oct 2017 | pharmaphorum

Advisers to the US regulator will meet today to discuss Spark Therapeutics' Luxturna, which could become the first gene therapy approved for an inherited disease in the US. However concerns about the treatment's safety and efficacy have been raise...

Original Article: FDA experts to vote on Spark's groundbreaking gene therapy

NEXT ARTICLE

More From BioPortfolio on "FDA experts to vote on Spark's groundbreaking gene therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...